25C-NBF
NBF-2C-C
 
2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-fluorophenyl)methyl]ethan-1-amine
2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-fluorobenzyl)ethan-1-amine
 1264 ·  C17H19ClFNO2 ·  323.79
 InChI=1S/C17H19ClFNO2/c1-21-16-10-14(18)17(22-2)9-12(16)7-8-20-11-13-5-3-4-6-15(13)19/h3-6,9-10,20H,7-8,11H2,1-2H3
 AHIUIEOLKNDLSC-UHFFFAOYSA-N This stereoisomer Any stereoisomer
 COc1cc(Cl)c(cc1CCNCc1ccccc1F)OC

Hansen, M. Design and synthesis of selective serotonin receptor agonists for positron emission tomography imaging of the brain. Ph. D. Thesis, University of Copenhagen, 16 Dec 2012. 7.9 MB.

Leth-Petersen, S; Bundgaard, C; Hansen, M; Carnerup, MA; Kehler, J; Kristensen, JL. Correlating the metabolic stability of psychedelic 5-HT2A agonists with anecdotal reports of human oral bioavailability. Neurochem. Res., 12 Feb 2014, 39 (10), 2018-2023. 625 kB. https://doi.org/10.1007/s11064-014-1253-y

EMCDDA. New drugs in Europe, 2015, European Monitoring Centre for Drugs and Drug Addiction, 1 May 2016. 1.0 MB. #75

Hansen, M; Phonekeo, K; Paine, JS; Leth-Petersen, S; Begtrup, M; Bräuner-Osborne, H; Kristensen, JL. Synthesis and structure–activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists. ACS Chem. Neurosci., 19 Mar 2014, 5 (3), 243-249. 21.5 MB. https://doi.org/10.1021/cn400216u #3c

13 November 2018 · Creative Commons BY-NC-SA ·